Charles Albright Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Charles Albright.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Charles Albright. Charles Albright is a Chief Scientific Officer in Editas Medicine, Inc. ($EDIT) and a EVP/Chief Scientific Officer in Editas Medicine, Inc. ($EDIT).

Address: C/O EDITAS MEDICINE, INC. CAMBRIDGE 02142 MA

Companies in which Charles Albright is an Insider

Editas Medicine, Inc.

Trading Symbol: EDIT
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Charles Albright: EVP/Chief Scientific Officer, Chief Scientific Officer
Holdings: 34,907 shares
Current Value: $647,874
Latest Transaction: Dec 17 2020
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Charles Albright

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...Option ExerciseM16.5110,000165,100145,000
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS64.3920012,87824,90725.1 K to 24.9 K (-0.80 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS63.844,024256,89225,10729.1 K to 25.1 K (-13.81 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS62.745,776362,38629,13134.9 K to 29.1 K (-16.55 %)
Dec 17 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...BuyM16.5110,000165,10034,90724.9 K to 34.9 K (+40.15 %)
Dec 11 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...Option ExerciseM16.5110,000165,100155,000
Dec 11 2020EDITEditas Medicine, I ...Albright CharlesEVP/Chief Scientifi ...SellS45.0010,000450,00024,90734.9 K to 24.9 K (-28.65 %)

View all Charles Albright insider transactions.